174 related articles for article (PubMed ID: 21196392)
1. The stem cell fitness landscape and pathways of molecular leukemogenesis.
Bagby GC; Fleischman AG
Front Biosci (Schol Ed); 2011 Jan; 3(2):487-500. PubMed ID: 21196392
[TBL] [Abstract][Full Text] [Related]
2. Significance of Clonal Mutations in Bone Marrow Failure and Inherited Myelodysplastic Syndrome/Acute Myeloid Leukemia Predisposition Syndromes.
Schaefer EJ; Lindsley RC
Hematol Oncol Clin North Am; 2018 Aug; 32(4):643-655. PubMed ID: 30047417
[TBL] [Abstract][Full Text] [Related]
3. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Sun L; Babushok DV
Blood; 2020 Jul; 136(1):36-49. PubMed ID: 32430502
[TBL] [Abstract][Full Text] [Related]
4. Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia.
Savage SA; Dufour C
Semin Hematol; 2017 Apr; 54(2):105-114. PubMed ID: 28637614
[TBL] [Abstract][Full Text] [Related]
5. Introduction to Acquired and Inherited Bone Marrow Failure.
Sieff CA
Hematol Oncol Clin North Am; 2018 Aug; 32(4):569-580. PubMed ID: 30047411
[TBL] [Abstract][Full Text] [Related]
6. Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016.
Zeidan AM; Battiwalla M; Berlyne D; Winkler T
Leuk Res; 2017 Feb; 53():8-12. PubMed ID: 27923195
[TBL] [Abstract][Full Text] [Related]
7. Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
Manabe A
Int J Hematol; 2016 Apr; 103(4):359. PubMed ID: 26899856
[No Abstract] [Full Text] [Related]
8. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
[TBL] [Abstract][Full Text] [Related]
9. Germline GATA2 Mutation and Bone Marrow Failure.
McReynolds LJ; Calvo KR; Holland SM
Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422
[TBL] [Abstract][Full Text] [Related]
10. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2014.
Visconte V; Lindsley RC; Berlyne D
Leuk Res; 2015 Jan; 39(1):110-3. PubMed ID: 25435026
[TBL] [Abstract][Full Text] [Related]
11. The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes.
Cada M; Segbefia CI; Klaassen R; Fernandez CV; Yanofsky RA; Wu J; Pastore Y; Silva M; Lipton JH; Brossard J; Michon B; Abish S; Steele M; Sinha R; Belletrutti M; Breakey V; Jardine L; Goodyear L; Sung L; Shago M; Beyene J; Sharma P; Zlateska B; Dror Y
Haematologica; 2015 May; 100(5):633-42. PubMed ID: 25682607
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow failure as a risk factor for clonal evolution: prospects for leukemia prevention.
Bagby GC; Meyers G
Hematology Am Soc Hematol Educ Program; 2007; ():40-6. PubMed ID: 18024607
[TBL] [Abstract][Full Text] [Related]
13. Acute myelogenous leukemia with PIG-A gene mutation evolved from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome.
Tanaka H; Imamura N; Oguma N; Shintani T; Tanaka K; Hyodo H; Oda K; Kimura A
Int J Hematol; 2001 Feb; 73(2):206-12. PubMed ID: 11372733
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.
Layton DM; Mufti GJ
Blut; 1986 Dec; 53(6):423-36. PubMed ID: 3542084
[TBL] [Abstract][Full Text] [Related]
15. Hereditary Predispositions to Myelodysplastic Syndrome.
Bannon SA; DiNardo CD
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27248996
[TBL] [Abstract][Full Text] [Related]
16. [Gene mutations in bone marrow failure syndromes].
Yoshizato T; Makishima H
Rinsho Ketsueki; 2016; 57(12):2519-2525. PubMed ID: 28090021
[TBL] [Abstract][Full Text] [Related]
17. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review.
Frietsch JJ; Dornaus S; Neumann T; Scholl S; Schmidt V; Kunert C; Sayer HG; Hochhaus A; La Rosée P
Eur J Haematol; 2014 Sep; 93(3):247-59. PubMed ID: 24635656
[TBL] [Abstract][Full Text] [Related]
19. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
Tamura S; Kanamaru A; Takemoto Y; Kakishita E; Nagai K
Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
[TBL] [Abstract][Full Text] [Related]
20. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
